Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cell Chemical Biology|April 2, 2026
IAP-based biodegraders can convert necroptosis to apoptosis and eliminate cancer driving protein complexesXiuquan Ma, François Vaillant, Deepagan Gopal, et al.
Diabetes|January 11, 2015
The RabGAP TBC1D1 plays a central role in exercise-regulated glucose metabolism in skeletal muscleJacqueline Stöckli, Christopher C Meoli, Nolan J Hoffman, et al.
The Biochemical Journal|August 11, 2025
Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosisVeerasikku Gopal Deepagan, Xiuquan Ma, Farzaneh Bazregari, et al.
The Journal of Biological Chemistry|August 18, 2016
Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 PseudokinasesLing Liu, Yu Wei Phua, Rachel S Lee, et al.
Science Advances|July 9, 2025
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitorsFarzaneh Shojaee, Esmaeel Azadian, Min Xian Wong, et al.
Nature Communications|June 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signalingMichael J Roy, Minglyanna G Surudoi, Ashleigh Kropp, et al.
Nature Communications|January 19, 2019
Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformationXiuquan Ma, Luxi Zhang, Jiangning Song, et al.
Oncogene|January 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancerXue Yang, Miguel I Cruz, Elizabeth V Nguyen, et al.
Molecular & Cellular Proteomics : MCP|May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor MicroenvironmentElizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancerXue Yang, Xiuquan Ma, Tianyue Zhao, et al.
Pageof 5